CD19, ALDH18A1, and CACNA1G as Significant Hub Genes in End-Stage Osteoarthritis

Area of Science:

• * Molecular Biology
• * Genomics
• * Bioinformatics

Background:

• * Osteoarthritis (OA) is a leading cause of chronic joint disease and disability in older adults.
• * Understanding the molecular mechanisms of end-stage OA is crucial for developing effective treatments.
• * This study focuses on identifying key molecular players in advanced OA.

Purpose of the Study:

• * To identify differentially expressed genes (DEGs) in end-stage knee osteoarthritis.
• * To elucidate associated signaling pathways and molecular interactions in OA.
• * To discover potential therapeutic targets for end-stage osteoarthritis.

Main Methods:

• * Analysis of messenger RNA (mRNA) expression data from the GSE32317 dataset using GEO2R.
• * Gene Ontology (GO) enrichment, Kyoto Encyclopedia of Genes and Genomes (KEGG), and protein-protein interaction (PPI) analyses.
• * Investigation of microRNAs targeting identified hub genes using the miRcode database.

Main Results:

• * Identified 134 downregulated and 189 upregulated genes in end-stage knee OA.
• * Determined four key hub genes: IL-1B, CD19, CACNA1G, and ALDH18A1.
• * Revealed involvement of these genes in Wnt signaling, B cell receptor signaling, calcium signaling, and other pathways.

Conclusions:

• * This research provides novel insights into the molecular landscape of end-stage osteoarthritis.
• * Identified hub genes (CD19, CACNA1G, ALDH18A1) and their associated pathways represent potential therapeutic targets.
• * Further investigation into these targets could lead to new strategies for managing advanced OA.